EMA Adopts a Positive Opinion for a New Route of Administration Together with a New Pharmaceutical Form and a New Strength for Isatuximab By Ogkologos - May 8, 2026 193 0 Facebook Twitter Google+ Pinterest WhatsApp It is a cancer medicine used to treat adult patients with multiple myeloma Source RELATED ARTICLESMORE FROM AUTHOR Non-pharmacological interventions – are they important to patients with cancer? Two novel bispecific antibodies in combination with chemotherapy show efficacy in neuroendocrine carcinomas Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small cell lung cancer MOST POPULAR Significant OS Benefit with Glofitamab plus GemOx in Transplant-Ineligible Patients with... December 6, 2024 A Summer Poem August 20, 2021 Study Shows CAR T-Cell Therapy Is Effective at Putting Childhood Leukemia... December 12, 2022 Additional Translations of the ESMO Patient Guides Now Available in the Croatian May 18, 2026 Load more HOT NEWS Elderly Woman Seeks Trick-Or-Treaters Who Surprised Her With Gifts The Day... Health inequalities: Why is it harder for some people to eat... Smoking among young adults increased by 25% during first lockdown FDA Approves Avapritinib for Advanced Systemic Mastocytosis
